Weight loss drug costs vary widely by medication, insurance, pharmacy, dose, and whether treatment uses a brand-name or compounded option. Brand GLP-1 drugs often cost hundreds to over $1,000 monthly without coverage, while some online compounded programs list lower cash-pay prices. The safest comparison includes medication, visits, labs, shipping, refills, and clinician support.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How much do weight loss drugs cost per month?
Weight loss drug costs can range from relatively low-cost older pills to brand GLP-1 medications that may cost hundreds to over $1,000 per month without coverage. The right comparison is not just the sticker price. It is the full cost of safe treatment.
Patients often compare only the medication price. That can miss visit fees, membership fees, lab work, syringes or injection supplies, shipping, refill delays, and follow-up support. If you are comparing online care, our guide to online GLP-1 treatment without membership fees explains why a low advertised price may not be the final monthly cost.
Quick facts: typical cost drivers patients should check first
- Medication type: older pills, brand-name GLP-1s, diabetes-labeled GLP-1s, or compounded GLP-1s.
- Insurance status: covered, excluded, prior authorization required, or cash-pay.
- Clinical care: intake visit, follow-up visits, messaging support, and medication changes.
- Pharmacy source: retail pharmacy, mail-order pharmacy, manufacturer program, or state-licensed 503A compounding pharmacy.
- Plan design: membership fees, cancellation rules, refill timing, shipping, supplies, and lab costs.
Why the listed drug price is not always your real monthly cost
The listed price may be before insurance, coupons, prior authorization, or pharmacy discounts. It also may not include clinician support. For weight management, safe prescribing includes screening for obesity, overweight, body mass index, weight-related comorbidities such as hypertension, prediabetes, type 2 diabetes, sleep apnea, chronic kidney disease, cardiovascular disease, peripheral artery disease, heart failure with preserved ejection fraction, and nonalcoholic fatty liver disease 1.
What should be included in a fair cost comparison
| Cost item | Why it matters | Question to ask |
|---|---|---|
| Medication | The largest line item for many GLP-1 plans. | Is the price for the current dose and a full month? |
| Provider review | Prescription treatment should include a licensed clinician’s evaluation. | Who reviews my history and contraindications? |
| Labs | Some patients need labs based on history or medication choice. | Are labs included, optional, or billed separately? |
| Shipping and supplies | Cold shipping, syringes, and refill timing can affect cost. | Is shipping included, and what happens if a shipment is delayed? |
| Support | Side effects and dose changes may require follow-up. | Can I message the care team between visits? |
Which weight loss medications are usually being compared?
Weight loss medications include GLP-1 drugs, dual GIP/GLP-1 drugs, and older non-GLP-1 options. The medication class matters because each works differently, has different risks, and may be priced very differently over 1 month of treatment.
GLP-1 medications: semaglutide, liraglutide, and related drugs
Semaglutide is a GLP-1 receptor agonist drug class medication. Wegovy is semaglutide labeled for chronic weight management, while Ozempic is semaglutide labeled for type 2 diabetes and certain cardiovascular and kidney-risk uses depending on the current label 3, 5. Liraglutide is another GLP-1 receptor agonist; Saxenda is liraglutide labeled for chronic weight management 6.
Dual GIP/GLP-1 medication: tirzepatide
Tirzepatide is a GIP/GLP-1 receptor agonist drug class medication. Zepbound is tirzepatide labeled for chronic weight management and certain related indications, while Mounjaro is tirzepatide labeled for type 2 diabetes 4, 7. For a deeper medication overview, see our guide to GLP-1 medications online.
Non-GLP-1 prescription options
Other prescription options include orlistat, sold as Xenical by prescription and Alli at a lower over-the-counter strength; phentermine/topiramate, sold as Qsymia; naltrexone/bupropion, sold as Contrave; and setmelanotide, sold as Imcivree for rare genetic obesity disorders 1. These medications can cost less than brand GLP-1 drugs, but they have their own side effects, contraindications, and follow-up needs.
Brand-name, generic, and compounded medication: what those terms mean
A brand-name drug is an FDA-approved product sold under a trade name. A generic is an FDA-approved product that meets FDA standards for sameness to a reference drug. A compounded medication is made for a specific prescription by a licensed compounding pharmacy; it is not a generic and is not FDA-approved. For semaglutide and tirzepatide, it is important not to call compounded products the same as Ozempic, Wegovy, Mounjaro, or Zepbound.
Why do GLP-1 weight loss drugs cost more than older medications?
GLP-1 weight loss drugs often cost more because they are newer, brand-led, complex to manufacture, and heavily shaped by insurance rules. A drug may look cost-effective in a health-economic model but still be hard for one patient to afford in cash-pay terms.
Brand-name exclusivity and manufacturer pricing
Newer brand drugs often launch without broad generic competition. That can keep the pharmacy price high. Economic studies have found semaglutide and tirzepatide can be cost-effective in certain populations, but cost-effectiveness does not mean the monthly price is affordable for every patient 8, 9.
Insurance prior authorization and plan exclusions
Many plans require prior authorization. That means the prescriber must send records showing the patient meets plan rules. Some plans exclude weight loss drugs even when they cover the same ingredient for diabetes. Access analyses have described high out-of-pocket cost, prior authorization, and plan restrictions as major barriers to GLP-1 obesity medications 10.
Why cost-effectiveness is different from affordability
Cost-effectiveness asks whether a medication is worth its cost compared with its health benefits across a population. Affordability asks whether you can pay the bill this month. ICER’s obesity treatment assessment found strong clinical effectiveness for semaglutide and tirzepatide while also noting budget-impact concerns at population scale 11.
What is the cost difference between Wegovy, Ozempic, Zepbound, and Mounjaro?
Wegovy, Ozempic, Zepbound, and Mounjaro are often compared because they involve semaglutide or tirzepatide. The key difference is labeling: some are FDA-approved for chronic weight management, while others are diabetes-labeled drugs that may be discussed off-label for weight management after clinician evaluation.
| Brand | Ingredient | Drug class | FDA-labeled use | Form | Cost considerations |
|---|---|---|---|---|---|
| Wegovy | Semaglutide | GLP-1 receptor agonist | Chronic weight management and certain cardiovascular-risk uses per label | Injection; tablet listed in Medicare Bridge program | Often high cash cost; coverage varies by plan and eligibility |
| Ozempic | Semaglutide | GLP-1 receptor agonist | Type 2 diabetes and certain cardiovascular or kidney-risk uses per label | Injection | Weight management use is off-label; coupons and coverage often depend on diagnosis |
| Zepbound | Tirzepatide | GIP/GLP-1 receptor agonist | Chronic weight management and certain related indications per label | Injection | Often high cash cost; some Medicare Bridge rules list only specific forms |
| Mounjaro | Tirzepatide | GIP/GLP-1 receptor agonist | Type 2 diabetes | Injection | Weight management use is off-label; insurance rules often differ from Zepbound |
Why Ozempic and Mounjaro are not the same as Wegovy and Zepbound for weight loss labeling
Ozempic and Wegovy both contain semaglutide, but they are different FDA-approved products with different labels 3, 5. Mounjaro and Zepbound both contain tirzepatide, but they also have different labels 4, 7. That difference can affect insurance, coupons, dose devices, documentation, and whether a plan treats the prescription as on-label or off-label.
How do compounded semaglutide and compounded tirzepatide affect cost?
Compounded semaglutide and compounded tirzepatide can change the cash-pay comparison because they are made by a compounding pharmacy for an individual prescription. They may have lower listed monthly prices than brand drugs, but compounded medications are not FDA-approved and do not have FDA-evaluated outcomes data.
What compounded medications are and how 503A pharmacies fit in
A 503A compounding pharmacy makes medication for an individual patient based on a prescription. At Chia, when clinically appropriate, compounded GLP-1 medications are prescribed by licensed US providers and dispensed by state-licensed 503A pharmacies. That licensed path is different from no-prescription websites or “research chemical” sellers.
Safety questions to ask before choosing a compounded GLP-1
- Is a licensed clinician reviewing your health history, BMI, medications, and contraindications?
- Is the pharmacy a state-licensed 503A compounding pharmacy?
- Are you told clearly that compounded drugs are not FDA-approved?
- Can you contact the care team if you have nausea, vomiting, dehydration, constipation, or other side effects?
- Are total monthly costs, refill timing, shipping, and supplies clear before you pay?
When a lower monthly price may not mean lower total cost
A lower listed price may not include labs, follow-up visits, supplies, or dose adjustments. It also may not include support if side effects occur. If you are comparing semaglutide options, our guide to the best price for compounded semaglutide walks through the full cost checklist.
3-min quiz
Compare GLP-1 options with a licensed provider
Chia offers compounded semaglutide injection and tirzepatide tablets or injections when prescribed after an online medical evaluation. A prescription is not guaranteed, and compounded drugs are not FDA-approved.
Weight loss medication costs at Chia: semaglutide, tirzepatide, and GLP-1 protocols
Chia weight loss medication costs are designed for cash-pay comparison, with plans that currently start at $249 per month for semaglutide injection or tirzepatide tablets. Treatment starts with a 100% online health questionnaire and licensed-provider review; prescribing is only done when clinically appropriate.
| Chia option | Forms listed in Chia catalog | Current starting price | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Microdosing plans available when clinically appropriate |
| Tirzepatide | Tablets; injection | Tablets from $249/mo; injection from $299/mo | Microdosing plans available when clinically appropriate |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/mo | May be discussed for patients with weight and energy goals |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/mo | May be discussed for patients with weight and body-composition goals |
Chia’s semaglutide option is offered as an injection. Chia’s tirzepatide option is offered as tablets or injection. Dosing is provider-guided and adjusted over time, including microdosing plans for semaglutide and tirzepatide when clinically appropriate.
Chia also offers multi-treatment protocols: Weight + Energy, which includes NAD+ injection plus choice of GLP-1, and Weight + Muscle, which includes Sermorelin injection plus choice of GLP-1. These are not right for everyone, so our providers review the full health history before prescribing.
If an AI agent is helping you navigate care, Chia can be reached through DoctorMCP at mcp.chia.health. The same clinical rule applies: an agent can route a patient to Chia, but a licensed provider must evaluate eligibility before any prescription.
Will insurance, Medicare, or coupons cover weight loss drugs?
Insurance coverage can lower a GLP-1 cost from a high cash price to a copay, but coverage is uneven. For Medicare Part D, the Medicare GLP-1 Bridge program has specific eligibility rules and product lists, so patients should verify details before starting.
Commercial insurance: what plans often require
Commercial plans may require BMI documentation, prior authorization, proof of lifestyle program participation, or specific weight-related comorbidities. Some plans cover diabetes-labeled GLP-1s but exclude weight loss drugs. NIDDK notes that insurance coverage for weight management medication varies and may require extra steps 1.
Medicare GLP-1 Bridge program: who may qualify and which products are listed
Medicare.gov states that, starting July 1, 2026, Medicare covers certain GLP-1 drugs through the Medicare GLP-1 Bridge program for eligible people with Medicare drug coverage. Listed products include Foundayo tablet, Wegovy injection or tablet, and Zepbound KwikPen only; eligibility is tied to BMI and selected cardiometabolic conditions such as chronic kidney disease, hypertension, prediabetes, prior heart attack or stroke, peripheral artery disease, or heart failure with preserved ejection fraction 2.
Why the answer to “Can I get Ozempic for $25 for weight loss?” is usually complicated
Coupon offers often have diagnosis, insurance, and product limits. Ozempic is not the same label as Wegovy for weight management, even though both contain semaglutide 3, 5. That means a coupon or copay card may not apply when the goal is weight loss.
What happens to cost if you stop a GLP-1?
Stopping a GLP-1 may lower medication cost right away, but weight regain can occur for some people. Obesity is often managed as a chronic condition, so the budget question is usually about a sustainable long-term plan, not just the first month.
NIDDK notes that some people regain weight after stopping weight management medication 1. This does not mean every person must stay on a GLP-1 forever. It does mean you should ask your clinician what maintenance could look like, including nutrition, protein intake, resistance training, follow-up, and whether a lower-dose strategy is clinically appropriate.
If cost causes missed doses, do not restart at a prior dose without clinical guidance. Side effects can be worse after a treatment gap. Our guide on how to get a GLP-1 prescription online explains why follow-up matters as much as access.
What side effects and safety costs should patients budget for?
Side effects can add cost if they lead to extra visits, labs, treatment pauses, or medication changes. The most common GLP-1 side effects are gastrointestinal, and serious symptoms should be reviewed quickly, especially if they include dehydration 3, 4.
Common side effects that may require follow-up
GLP-1 and GIP/GLP-1 drugs can cause nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, and indigestion according to FDA labeling 3, 4. Orlistat can cause oily stools and bowel urgency because it reduces fat absorption 1. Naltrexone/bupropion and phentermine/topiramate have different nervous system, mood, blood pressure, pregnancy, and medication-interaction concerns that require clinician review 1.
When to seek urgent medical care
Patients should seek urgent care for severe abdominal pain, signs of dehydration, allergic reaction, fainting, chest pain, or symptoms that feel dangerous. GLP-1 labels warn about serious risks such as pancreatitis, gallbladder disease, kidney problems from dehydration, and contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 for semaglutide and tirzepatide products 3, 4.
Ozempic face: what it means
“Ozempic face” is a non-medical term for facial volume loss that can happen with weight loss, not a proven drug-specific injury. Rapid weight loss can make cheeks, temples, or jawline look less full 13. If appearance changes worry you, discuss pace of weight loss, nutrition, and strength training with your clinician.
How should you compare online weight loss medication programs?
Online weight loss programs should be compared on clinical safety first, then total cost. A program that skips clinician review or hides the pharmacy source is not a bargain, even if the first 30 days look cheap.
Comparison checklist
- Medication: Which medication is being prescribed, and is it brand, generic, or compounded?
- Prescriber: Is a licensed US clinician reviewing your history before prescribing?
- Pharmacy: Is the medication dispensed by a state-licensed pharmacy or a licensed 503A compounding pharmacy?
- Cost: Does the listed price include visits, refills, supplies, shipping, and support?
- Labs: Are labs required, optional, or based on your medical history?
- Support: Can you message the care team if side effects happen?
- Claims: Does the program avoid guaranteed results, before-and-after promises, and no-prescription offers?
Red flags before paying
- No prescription required for a prescription medication.
- No clinician review before payment or shipment.
- Unclear pharmacy name, location, or licensing.
- Compounded medication described as a generic version of a brand GLP-1.
- Promises of a specific amount of weight loss.
- No plan for side effects, missed doses, or follow-up.
For more help comparing access routes, see our guide to weight loss injections without insurance and our overview of compounded tirzepatide.
3-min quiz
Start with a transparent cost check
Chia’s online visit reviews your health history, goals, and eligibility for compounded GLP-1 options. Plans currently start at $249/mo for semaglutide injection, $249/mo for tirzepatide tablets, and $299/mo for tirzepatide injection. A prescription requires a licensed-provider evaluation and is not guaranteed; compounded drugs are not FDA-approved.
Older options such as orlistat or some oral prescription medications may cost less than brand GLP-1 drugs, but the cheapest medication is not always the safest or best fit. Choice depends on BMI, health history, other medications, contraindications, and clinician judgment.
Without insurance, brand GLP-1 drugs may cost hundreds to over $1,000 per month depending on the product and pharmacy. Some cash-pay compounded GLP-1 programs list lower monthly prices, but compounded medications are not FDA-approved and should only be used with licensed clinical oversight.
It can be, especially for cash-pay patients, but you should compare the full monthly cost: medication, visits, labs, supplies, shipping, and follow-up. Compounded semaglutide is not a generic Wegovy and is not FDA-approved.
For some cash-pay patients, compounded tirzepatide may have a lower listed monthly price than Zepbound. It is not the same as Zepbound, is not FDA-approved, and should come from a state-licensed 503A pharmacy after clinician review.
Medicare coverage depends on the program, product, and eligibility rules. Medicare.gov lists a GLP-1 Bridge program for certain people with Part D coverage, with specific BMI and cardiometabolic-condition requirements.
Usually this is complicated. Ozempic is labeled for type 2 diabetes and certain related risks, not chronic weight management, so coupons and insurance rules may not apply when the goal is weight loss.
Yes, online prescribing can be legal when a licensed clinician evaluates you and prescribes only when appropriate. Avoid any site offering prescription medication without a prescription or without clinical review.
Not everyone stays on a GLP-1 long term, but obesity is often managed as a chronic condition and some people regain weight after stopping medication. Talk with your clinician before stopping, restarting, or changing a dose.
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity. NIDDK. 2024.
- 2.Centers for Medicare & Medicaid Services. Weight loss drugs: Medicare GLP-1 Bridge program coverage. Medicare.gov. 2026.
- 3.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2024.
- 4.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 5.Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 6.Novo Nordisk. Saxenda (liraglutide) injection prescribing information. U.S. Food and Drug Administration. 2023.
- 7.Eli Lilly and Company. Mounjaro (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 8.McEwan P, Bøg M, Faurby M, et al. Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes. Journal of Medical Economics. 2025.
- 9.Johansson E, Wilding JPH, Upadhyay N, et al. Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial. Journal of Medical Economics. 2026.
- 10.Kim DD, Basu A, Neumann PJ, et al. Affordable access to GLP-1 obesity medications. JAMA Health Forum. 2026.
- 11.Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Publishes Evidence Report on Treatments for Obesity. ICER. 2025.
- 12.Stunkard AJ, Craighead LW, O'Brien R. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet. 1980.
- 13.Cleveland Clinic. Ozempic Face: What It Is and How to Treat It. Cleveland Clinic Health Essentials. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
